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Abstract
The alveolar epithelium serves as a barrier between organism and environment and functions as the first line of protection
against potential respiratory pathogens. Alveolar type II (TII) cells have traditionally been considered the immune cells of the
alveolar epithelium, as they possess immunomodulatory functions; however, the precise role of alveolar type I (TI) cells,
which comprise ,95% of the alveolar epithelial surface area, in lung immunity is not clear. We sought to determine if there
was a difference in the response of TI and TII cells to lung injury and if TI cells could actively participate in the alveolar
immune response. TI cells isolated via fluorescence activated cell sorting (FACS) from LPS-injured rats demonstrated greater
fold-induction of multiple inflammatory mediators than TII cells isolated in the same manner from the same animals. Levels
of the cytokines TNF-a, IL-6 and IL-1b from cultured primary rat TI cells after LPS stimulation were significantly increased
compared to similarly studied primary rat TII cells. We found that contrary to published reports, cultured TII cells produce
relatively small amounts of TNF-a, IL-6 and IL-1b after LPS treatment; the higher levels of cytokine expression from cultured
TII cells reported in the literature were likely from macrophage contamination due to traditional non-FACS TII cell isolation
methods. Co-culture of TII cells with macrophages prior to LPS stimulation increased TNF-a and IL-6 production to levels
reported by other investigators for TII cells, however, co-culture of TI cells and macrophages prior to LPS treatment resulted
in marked increases in TNF-a and IL-6 production. Finally, exogenous surfactant blunted the IL-6 response to LPS in cultured
TI cells. Taken together, these findings advocate a role for TI cells in the innate immune response and suggest that both TI
and TII cells are active players in host defense mechanisms in the lung.
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Introduction
The alveolar epithelium is an important component of the
innate immune response of the lung. By providing an anatomic
barrier that separates the organism from the external environ-
ment, the alveolar epithelium serves as a first line of defense
against potential inhaled pathogens. While the cells of the innate
immune system, such as alveolar macrophages and dendritic cells,
harbor the bulk of the responsibility for prompting an immune
reaction upon encountering inhaled pathogens, the cells that
comprise the alveolar epithelium have also been implicated in
aiding to trigger an inflammatory response.
The alveolar epithelium is comprised of two morphologically
different cell types – alveolar type I (TI) and alveolar type II (TII)
cells. TII cells, which cover 3–5% of the alveolar surface area, are
cuboidal epithelial cells with diameters of ,10 mm. TII cells have
been extensively studied and have been labeled defenders of the
alveolus for their immunomodulatory functions [1]. TII cells can
produce cytokines and chemokines, such as TNF-a, IL-6, IL-1b,
monocyte chemoattractant protein 1 (MCP-1), macrophage
inflammatory protein 1a (MIP-1a), growth related oncogene a
(GRO-a) and granulocyte-macrophage colony stimulating factor
(GM-CSF) in response to various forms of lung injury induced by
bacteria, viruses, or mechanical ventilation [2–4]. TII cells also
produce, secrete, and recycle surfactant, which can enhance
chemotaxis, bacterial uptake and phagocytosis by alveolar
macrophages [5,6], but can also inhibit cytokine production in
response to LPS [7]. Far less is known about the potential of TI
cells to participate in the inflammatory response. TI cells are large,
thin squamous epithelial cells with diameters that range up to
100 mm and cell bodies that can be as thin as 50 nm [8]. TI cells
comprise 95% of the alveolar epithelium, making them a major
component of the physical barrier to respiratory pathogens.
Despite this fact, the prevailing paradigm has been that TII cells
are the inflammatory cells of the alveolar epithelium, while TI cells
help form the mechanical barrier to pathogens but do not
participate in the active cellular immune response of the lung.
Newer data led us to reconsider the current thoughts
surrounding the role of TI cells in alveolar inflammation. TI cells
contain toll-like receptor 4 (TLR4), a receptor for lipopolysaccha-
ride (LPS), a cell wall protein found on gram negative bacteria,
and primary rat TI cells have been shown to produce the pro-
inflammatory cytokines TNF-a, IL-6 and IL-1b in response to
LPS stimulation [9]. Given these findings, particularly in the
context of the extensive alveolar surface area covered by TI cells,
we hypothesized that TI cells were capable of producing a wide
array of inflammatory mediators like their TII counterparts and
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that the alveolar microenvironment can influence TI cell cytokine
production.
We used fluorescence-activated cell sorting (FACS) to isolate
relatively pure populations of TI and TII cells for our studies. We
performed PCR array analysis on primary rat TI and TII cells
isolated by FACS from LPS-injured and non-injured control
animals to compare their inflammatory profiles. To isolate the
specific responses to LPS treatment from each cell type, we
cultured FACS-isolated TI and TII cells, treated the cells with
LPS, and then measured pro-inflammatory cytokine secretion
using ELISA. We discovered that TI cells produce more cytokines
per cell after LPS treatment than TII cells, but this effect was
magnified by the fact that TII cells produced relatively small
amounts of TNF-a, IL-6 or IL-1b in response to LPS, which is
contrary to previously published reports [10–12]. We discovered
that the discrepancies between our results and those of other
investigators were due to the method of TII cell isolation, and that
contamination of TII cell preparations by macrophages accounted
for the observed differences in cytokine expression. Alveolar
macrophages are dominant mediators of lung immunity, patrolling
the epithelial surface to phagocytize invading pathogens and
generating cytokines and chemokines to recruit neutrophils to
augment the immune response [13]. Given the differences seen in
the response of TI and TII cells to LPS stimulation and the effect
of co-culturing TII cells with macrophages, we sought to evaluate
how elements of the alveolar microenvironment could affect TI
cells. Therefore, we also examined the effects of macrophages and
surfactant on the LPS-induced inflammatory response of TI cells.
The studies contained in this report not only suggest that TI
cells are capable of mounting an inflammatory response after LPS
exposure, but that the microenvironment surrounding both TI
and TII cells may contribute to their ability to secrete cytokines
and participate in the innate immune response. Determining how
TI cells respond to respiratory pathogens and clarifying their role
in the immune response in the lung may alter how lung immunity
is viewed and possibly produce new therapeutic targets for
addressing inflammation in the distal lung.
Methods
Ethics statement
All animal experiments were performed in accordance with,
and with the approval of, protocols sanctioned by the IACUC
committees at the University of California, San Francisco and the
San Francisco VA Medical Center (approval #10-075-01).
Animal studies
Pathogen-free, adult male Sprague-Dawley rats from Charles
River Laboratories (Hollister, CA) weighing ,150–200 g were
used in all experiments. All animals were housed and provided ad
libitum access to food and water. Rats were anesthetized by brief
inhalation of 4% isoflurane prior to intratracheal instillation of
normal saline (control) or LPS 10 mg/kg (Escherichia coli
endotoxin serotype O127:B8 (Sigma-Aldrich, St. Louis, MO))
[14] through a 24-gauge angiocatheter inserted into the trachea.
After instillation, the animals were allowed to recover from the
anesthesia, and were euthanized at various timepoints with an
intraperitoneal injection of pentobarbital (100 mg/kg) before
removal of the lungs.
Cell isolation
FACS isolation of alveolar TI and TII cells. Adult Sprague
Dawley rats were euthanized with an intraperitoneal injection of
pentobarbital (100 mg/kg). Alveolar TI and TII cells were isolated
from the lungs by FACS using methods described by Gonzalez et
al [15]. After enzymatic digestion with porcine grade IV elastase
(Sigma), the lungs were minced to produce a single cell suspension
that was then subjected to FACS using alveolar epithelial cell
antibodies that are specific, within the lung, to the apical
membranes rat TI (RTI40) [16] or rat TII (RTII70) [17] cells
(kind gifts from Dr. Leland Dobbs, UCSF). One rat was used for
each isolation; the typical yield was ,1.56106 TI cells or 86106
TII cells per animal. Cell purity was determined via immunocy-
tochemical staining of samples using RTI40 to label TI cells and
RTII70 to label TII cells. Cell preparations containing .2% of
contaminating cells were discarded; .95% of all cells were viable
as measured by a Live/Dead kit (Invitrogen, Carlsbad, CA).
Non-FACS isolation of alveolar TII cells. TII cells were
isolated using a conventional method of enzymatic digestion with
porcine elastase followed by panning over plates coated with IgG
to remove macrophages and leukocytes, as described previously
[17]. Preparations containing ,85% TII cells or .2% TI cells
were discarded. Cell purity was determined by cell-specific staining
with the appropriate antibodies to TII cells and DAPI, and .98%
of all cells were viable as measured by a Live/Dead kit
(Invitrogen).
Macrophages. The lungs of adult Sprague-Dawley rats were
lavaged 5 times with 7 ml aliquots of Ca+2/Mg+2-free PBS
containing 5 mM EDTA and 5 mM EGTA at 37uC. The aliquots
for each rat were pooled and centrifuged at 500 g for 12 minutes.
The cells were then collected, counted, and resuspended in
DMEM containing 1% penicillin-streptomycin and 10% fetal
bovine serum (Hyclone, Waltham, MA). In order to assess purity
of the preparations, cells were stained with a modified Wright
Giemsa stain, and reached purities of .95% macrophages.
Cell culture
Using the methods of Gonzales et al [15] and Wang et al [18],
TI cells isolated via FACS and were resuspended in DMEM-H16
containing 20% fetal bovine serum. The cells were then cultured
on Transwell plates at a density of 500,000 cells/well and allowed
to recover from the isolation and FACS procedures overnight in a
10%CO2/air incubator at 37uC. TII cells were resuspended in
DMEM-H16 with 10% fetal bovine serum, plated at the same
density, and cultured in 5% CO2 at 37uC [19]. The next day, LPS
10 ug/ml (Sigma) was added to the cells in serum-free media. Cells
were cultured for 18 hours prior to collection of supernatant and
cells. For studies that were focused on the NF-kB/IkB pathway,
cells were isolated from the lung in the exact same manner as
above, except they were not subject to FACS. Instead, the cells
were cultured on glass slides overnight before treatment with LPS
10 ug/ml for varying lengths of time – 10 minutes, 30 minutes,
1 hour, 4 hours, 8 hours and 18 hours. Cells were then spun at
700 rpm to adhere to the slide before fixation with paraformal-
dehyde and subsequent staining with antibodies as described
below.
Macrophages collected from the bronchoalveolar lavage were
added to cultured TI or TII cells (cultured at a density of 500,000
cells/well) in increasing numbers to represent cultures containing
5% (25,000), 10% (50,000), 15% (75,000) or 20% (100,000)
macrophages. Similar numbers of macrophages were cultured
alone as a control. For co-cultures of alveolar epithelial cells and
macrophages, 10% macrophages, equaling 50,000 macrophages,
were added.
RT2 Profiler PCR Array and Quantitative PCR
Approximately 2 mg total RNA were mixed with genomic DNA
elimination buffer prior to synthesis of cDNA using the RT2 First
TI and TII Cells and Inflammation
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Strand Kit (SABiosciences, Valencia, CA). The resulting cDNA
reaction was mixed with SYBR green qPCR master mix and
transferred into the 96-well RT2 Profiler PCR Array for Rat
Inflammatory Cytokines and Receptors (SABiosciences), contain-
ing appropriate primers for genes associated with the chemokines,
cytokines, and interleukins involved in the inflammatory response
as well as their receptors and primers for housekeeping genes.
Real-time PCR utilizing the RT2 Profiler PCR Array System was
performed according to manufacturer’s instructions utilizing an
ABI Prism 7500 RT-PCR thermocycler (Applied Biosystems,
Carlsbad, CA). Normalized threshold cycle data from the real-
time instrument were calculated and interpreted using the PCR
Array Data Analysis software tool (SABiosciences) which utilizes
the DDCT method of data analysis and normalizes all results to five
housekeeping genes. The relative expression of each gene in either
the TI or TII cells of the LPS-treated animals was compared with
the expression in the TI or TII cells of control animals; significance
was assessed by an unpaired Student’s t-test, with a p value of
#0.05 considered statistically significant. Validation of expression
for select genes was accomplished using quantitative real-time
PCR with gene expression assays purchased from Applied
Biosystems. Relative amounts of mRNA for the validation studies
were calculated using the comparative threshold method with 18S
RNA as the internal control. Significance was again assessed by an
unpaired Student’s t-test, with a p value of #0.05 being considered
significant.
Western blot analysis
After instillation of LPS or saline vehicle (for uninjured control)
into the lungs of rats, TI and TII cells were isolated via FACS
18 hours afterwards as described above. Protein lysates from
injured and uninjured TI and TII cells were studied using
standard Western blotting techniques. Antibodies used were
CCR5, SPP1 (Abcam, Cambridge, MA) and b-actin (Sigma).
Densitometric quantitation was performed using ImageJ software
(www.NIH.gov).
Immunohistochemistry
Immunohistochemistry was performed on cytocentrifuged
preparations of mixed rat lung cells. Adult Sprague-Dawley rats
were euthanized with an intraperitoneal injection of pentobarbital
(100 mg/kg) and the lungs were removed, digested with porcine
grade IV elastase (Sigma) and minced and then filtered to form a
single cell suspension, from which aliquots were taken and spun
down onto slides. These cytocentrifuged mixed lung cell prepa-
rations were then fixed in 4% paraformaldehyde prior to
immunohistochemical staining. Antibodies used were phospho-
IKKa/b (Cell Signaling Technologies, Danvers, MA), RTI40 and
RTII70. Secondary antibodies were conjugated to Alexa Fluor
488 or 594 (Invitrogen). Control slides utilized a non-specific IgG
primary antibody. All slides were mounted with Prolong Antifade
Reagent (Invitrogen) and images were captured with a Leica
DC500 camera on a Leica Orthoplan microscope.
Measurement of cytokines via Enzyme-Linked
Immunosorbent Assay (ELISA)
Cell culture supernatants were assayed using ELISA for TNF-a,
IL-6 (BD Biosciences, San Jose, CA) or IL-1b (R&D Systems,
Minneapolis, MN) per manufacturer’s instructions.
Surfactant isolation
Adult Sprague Dawley rats were euthanized as described above.
Bronchoalveolar lavage was collected by first instilling 3 ml of
10 mM PBS with Ca2+ and Mg2+ and then flushing the solution
back and forth into the lungs three times. The procedure was
repeated with another 3 ml three additional times and the BAL
from a single animal was pooled. The BAL was centrifuged at
500 g for 5 minutes to remove cells and cellular debris. The
supernatant was collected and protease inhibitors (Sigma) were
added prior to centrifugation at 27,000 g for 60 minutes. The
pellet, containing large aggregate surfactant, was collected and
resuspended in surfactant buffer (10 mM Tris, 154 mM NaCl,
1.5 mM CaCl2, pH 7.4) [20]. An aliquot was extracted and
assayed for total protein and phospholipid content (kindly
performed by Cheri Chapin, UCSF). Surfactant was added to
cells in culture; for studies involving the study of surfactant and
LPS, surfactant was added 2 hours prior to the addition of LPS.
Statistical Analysis
All experiments were performed a minimum of three times
unless otherwise stated. For comparisons between the control and
treated groups, unpaired Student’s t-test was employed. For
comparisons of multiple groups, a one-way analysis of variance
(ANOVA) followed by post-hoc analysis using the Bonferroni t-test
was conducted using GraphPad Prism 5.0 software (GraphPad,
San Diego, CA). A p value of ,0.05 was considered significant.
Results
Differential cytokine expression between TI and TII cells
Inflammatory gene expression analysis in rat TI and TII cells
was performed using a PCR array that assayed the expression of
84 genes affiliated with inflammation. We considered a gene to be
significantly differentially regulated if the difference in expression
between the cell types was .2-fold and the corresponding p value
was ,0.05. TI cells from control uninjured rats demonstrated a
statistically significant higher level of expression of multiple genes
(43 of 84 genes assayed) when compared to control uninjured TII
cells, with CCL3, CCL4, CCR1, CCR2, CCR5, IL10ra, IL1b,
IL2rb, SPP1 (secreted phosphoprotein 1 or osteopontin) and TNF
being the ten most differentially expressed (Figure 1A). TI cells
from LPS-injured animals demonstrated enhanced induction in 50
of the 84 genes assayed when compared to TII cells from the same
injured animals, with CCL21, CCL9, CCL5, CCR6, IL2rb,
IL2rg, IL6r, ITGAM (Integrin, alpha M), ITGB2 (Integrin, beta
2), SPP1, TNF and TNFrsf1b (TNF receptor superfamily, member
1b) exhibiting the most differential expression (Figure 1B). When
comparing TI cells from control animals to TI cells from LPS-
injured animals, despite the trend towards higher expression in TI
cells of nearly 1/3 of the genes from LPS-treated animals, only
three genes exhibited .2-fold increase that was statistically
significant: Casp1, CCL19 and CXCL4. In TII cells, only five
genes – CCL19, CRP, IL13, IL18 and LTA (lymphotoxin alpha
or TNF-b) – were significantly up-regulated in LPS- treated
animals compared to controls.
We selected five genes that had well-studied TaqMan qPCR
probes and primers available to validate our PCR array results
from our comparison of control TI and TII cells and of LPS-
stimulated TI and TII cells - CCL21, CCR5, IL6r, IL10ra and
SPP1. We chose to study CCL21, a C-C chemokine that is
chemotactic for thymocytes and activated T-cells in vitro, and
IL6r because they were the two most differentially expressed genes
of all assayed. We selected to validate SPP1 and CCR5, as they are
well-studied inflammatory mediators (see below), and IL10ra,
interleukin 10 receptor alpha, because its ligand, IL-10, is
considered an anti-inflammatory cytokine [21]. For each gene
studied, both control and LPS-treated TI cells exhibited greater-
TI and TII Cells and Inflammation
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fold expression than control or LPS-treated TII cells that was
statistically significant (Figure 2A), which is consistent with our
PCR array results. In the cases of IL10ra and CCL21, the relative
expression levels in LPS-treated TI cells was significantly greater
than in control TI cells (p,0.05). LPS-injured TI cells exhibited
.2-fold induction of both IL10ra and CCL21 in our PCR array,
but failed to reach statistical significance when compared to
expression in control TI cells.
Since many transcripts undergo post-transcriptional modifica-
tion, we examined whether our mRNA data translated into similar
differences in protein expression. We chose to measure the protein
expression of SPP1 and CCR5 as well-characterized antibodies
were available for these proteins. SPP1 is an important participant
in both innate and acquired immunity [22], acting as a
chemotactic factor for macrophages, dendritic cells and T cells
[23,24], and is strongly expressed in the alveolar macrophages of
patients with ARDS [24,25]. SPP1 also acts as an important signal
transducer that interacts with different pathways to mediate
immune responses. SPP1 can activate NF-kB transcription, which
promotes cytokine and inflammatory mediator expression [23]
either by signaling through the Src and FAK tyrosine kinases to
activate NF-kB, or by phosphorylating IkBa, an inhibitor of NF-
kB, which induces IkBa degradation and subsequent translocation
of NF-kB to the nucleus. Our qPCR data validated the finding of
high levels of SPP1 in LPS-injured TI cells. Western blotting of
lysates from both control and LPS-stimulated alveolar epithelial
cells demonstrated that TI cells contain more SPP1 than their TII
cell counterparts, and that injured TI cells had significantly more
SPP1 protein than either injured TII or control TI or TII cells. C-
C chemokine receptor 5 (CCR5), a member of the beta chemokine
receptor family, functions as a receptor for many C-C chemokines
including monocyte chemoattractant protein 2 (MCP-2), macro-
phage inflammatory protein-1a and -1b (MIP-1a, MIP-1b), and
regulated on activation normal T expressed and secreted protein
(RANTES) [26]. CCR5 is also a co-receptor for HIV-1 and the
target for the HIV drug Maraviroc [27]. Our qPCR validation
data indicate that CCR5 is more highly expressed in control TI
cells versus TII cells and in LPS-treated TI versus TII cells
(Figure 2A), however, the protein expression levels of CCR5 were
not statistically different among the cell types studied (Figure 2B),
suggesting that CCR5 in alveolar epithelial cells may undergo
more post-transcriptional modification than SPP1.
We anticipated that a higher number of genes in either LPS-
injured TI or TII cells would have been up-regulated compared to
their non-injured controls, given that prior data from our lab
demonstrated that TI cells in culture produce significantly more
TNF-a, IL-6 and IL-1b via ELISA analysis than controls after
LPS stimulation [9]. However, when isolating TI or TII cells from
LPS-injured rat lungs, we realize that we are actually studying
alveolar cells that have been exposed to their inflammatory milieu,
including macrophages, endothelia, surfactant, immune cells,
plasma factors, etc. In order to separate cell-specific responses to
LPS stimulation alone, we moved to an in vitro model.
Cultured TI cells produce more TNF-a, IL-6 and IL-1b than
cultured TII cells
TII cells are known to possess immunomodulatory functions,
including the ability to produce various cytokines upon stimulation
[3,10–12]. Both TI and TII cells were isolated from the lungs of
rats via FACS and cultured overnight to allow recovery from the
isolation procedure prior to the addition of LPS 10 mg/ml.
Eighteen hours later, the media was collected and assayed for
cytokine content via ELISA. At baseline, cultured TI cells
produced slightly more TNF-a (15.865.8 pg/ml) and IL-6
(41.666.6 pg/ml) than their TII cell counterparts (TNF-a
1.960.7 pg/ml; IL-6 37.768.0), while levels of IL-1b were nearly
equivalent for both cell types. However, after LPS stimulation, TI
cells produced significantly more TNF-a (997.26183.9), IL-6
(1201.9640.6) and IL-1b (37.7612.4) than TII cells (TNF-a
47.4612.1; IL-6 53.9614.1; IL-1b 8.963.6; *p,0.05) (Figure 3).
LPS did increase cytokine production in TII cells over baseline,
but only in the case of IL-6 was statistical significance reached
(**p,0.05).
Figure 1. Expression of inflammatory mediators in TI and TII
cells. RT2 Profiler Array for rat inflammatory cytokines and receptors
was performed with mRNA from TI and TII cells isolated from control
and LPS-injured rats (LPS 10 mg/kg). Results are expressed as fold
changes of the various genes as illustrated of control TI cells over
control TII cells (Figure 1A) and of LPS-stimulated TI cells over LPS-
stimulated TII cells (Figure 1B). The top 10 differentially expressed genes
are listed for control TI versus TII cells and the top 12 are listed for LPS-
stimulated TI versus TII cells. For each condition, n = 6 and *p,0.05.
doi:10.1371/journal.pone.0055545.g001
TI and TII Cells and Inflammation
PLOS ONE | www.plosone.org 4 January 2013 | Volume 8 | Issue 1 | e55545
TI and TII Cells and Inflammation
PLOS ONE | www.plosone.org 5 January 2013 | Volume 8 | Issue 1 | e55545
TII cells produce less cytokines than expected after LPS
treatment
Recent reports of TNF-a levels in primary TII cell cultures
range from ,800 to 1000 pg/ml 24 hours after LPS stimulation
at doses ranging from 0.01 to 10 mg/ml [10,11,28,29]. The levels
of cytokine expression in our FACS-isolated cultured TII cells
were notably less (Figure 3). The most obvious difference between
our findings and those published reports was that our TII cells
were isolated via FACS. In order to determine the cause of these
seemingly discordant results, we isolated TII cells utilizing a
standard published protocol for TII cell isolation [30] and treated
the TII cells in the exact same fashion as our FACS-isolated TII
cells: we placed the cells in culture in media with fetal bovine
serum overnight, stimulated the cells with LPS in serum-free
media the next morning, and collected the cells and supernatant
18 hours later. We chose to measure TNF-a and IL-6 secretion via
ELISA as the overall level of IL-1b production for both cell types
was low and alterations in levels of expression would be difficult to
appreciate. Both at baseline and after LPS stimulation, TII cells
isolated in the conventional manner (non-FACS) demonstrated
much higher levels of TNF-a (1882.46255.4 pg/ml) and IL-6
(406.3684.5 pg/ml) than TII cells isolated by FACS (TNF-a
59.0619.8 pg/ml; IL-6 56.2616.5 pg/ml) (Figure 4A). The
numbers for the non-FACS TII cells were more consistent with
published reports of LPS-induced cytokine production in TII cells,
suggesting that the difference in cytokine production may be due
in part to the contaminating macrophages present in each
preparation.
Alveolar macrophages stimulate TII cell cytokine
production in the presence of LPS
The conventional method of rat TII cell isolation typically
produces TII cell purities that are reported to be between 85–
97%, resulting in a 3–15% contamination rate, with macrophages
most often implicated as the contaminating cell type [12,31,32].
With FACS, we were able to achieve TII cell purities between 95–
98% (Figure 4B), resulting in a 2–5% rate of contamination. To
determine if contaminating macrophages could account for
enhanced cytokine expression in non-FACS cultured TII cells,
we isolated macrophages and added them to our FACS TII cells in
culture at varying concentrations. The numbers of macrophages
were chosen to reflect similar degrees of contamination of TII cell
preparations. The percentage of macrophages was calculated from
the number of alveolar epithelial cells used in the experiments
(500,000 cells/well), as previously described in Methods. When
stimulated with LPS, increasing the concentrations of macrophag-
es produced increasing amounts of TNF-a (5% Mac:
1328.46133.3; 10% Mac: 2341.66551.4 pg/ml, 15% Mac:
3834.56875.4 pg/ml, 20% Mac: 6021.061041.3 pg/ml) and
IL-6 (5% Mac: 73.7623.3 pg/ml, 10% Mac: 124.4643.4 pg/
ml, 15% Mac: 198.8671.6 pg/ml, 20% Mac: 302.4667.9 pg/ml)
Figure 2. Validating enhanced expression of inflammatory mediators. A. qPCR assay: IL6r, IL10ra, CCL21, CCR5 and SPP1 expression in TI
and TII cells isolated from control (n = 4) and LPS-injured (LPS 10 mg/kg) animals (n = 4) was measured using qPCR employing TaqMan probes and
primers. Relative to the expression of the above genes in TII cells of control animals, uninjured TI cells had higher levels of expression of all
inflammatory mediators studied. LPS injury increased cytokine transcripts of all genes compared to controls for TI and TII cells, but the only in the
case of IL10ra and CCL21 in injured TI cells was the fold-increase significant over uninjured TI cells (*p,0.05). Data is expressed as fold expression of
inflammatory mediator transcript over TII cell controls6 SEM; all values were normalized to 18S. B. Western blot analysis: Western blots of cell lysates
from TI and TII cells of control and LPS-injured (LPS 10 mg/kg) rats were probed with antibodies against CCR5 and SPP1. b-actin staining is shown to
exhibit equalization of protein loading. Blots represent 3 separate experiments. Densitometry measurements suggest that control TI cells contain
,20% more SPP1 than control TII cells, and injured TI cells contain ,30% more SPP1 protein than control TI cells. Both differences are statistically
significant. Furthermore, SPP1 protein expression from injured TI cells was significantly greater than from control TI cells. Control TI cells contain only
,5% more CCR5 than control TII cells and injured TI cells express ,15% more CCR5 than injured TII cells, but the differences were not statistically
significant. (*p,0.05).
doi:10.1371/journal.pone.0055545.g002
Figure 3. Cytokine response in cultured TI and TII cells
stimulated with LPS. TNF-a, IL-6 and IL-1b were detected in the
supernatants of cultured TI and TII cells isolated via FACS both at
baseline and after in vitro LPS (10 mg/ml) stimulation. TNF-a, IL-6 and IL-
1b production in LPS-stimulated cells was significantly increased over
baseline for TI cells (n = 5 for each cell type, *p,0.05). Levels of IL-6 in
LPS-stimulated TII cells were significantly greater than in control TII
cells. Results are expressed as mean level of cytokine 6 SEM; *p ,0.05
for control TI vs. LPS-treated TI cells, **p,0.05 for TII control vs. LPS-
treated TII cells.
doi:10.1371/journal.pone.0055545.g003
TI and TII Cells and Inflammation
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as expected. We then co-cultured FACS-isolated TII cells with
0%–20% macrophages and treated the cells with LPS prior to
measuring supernatant cytokine expression. We discovered that
increasing the number of macrophages predictably increased, in a
dose-dependent fashion, TNF-a production (TII+0% Mac:
47.3612.1 pg/ml; TII+5% Mac: 1090.36402.3 pg/ml;
TII+10% Mac: 1910.66658.3 pg/ml; TII+15% Mac:
3770.46688.1 pg/ml; TII+20% Mac: 4137.261559.9 pg/ml) to
levels that have been reported in the literature for TII cells
stimulated with LPS [11,28]. Co-culturing FACS-isolated TII cells
with 5–20% macrophages increased IL-6 production over LPS-
stimulated TII cells alone, but the levels were not statistically
different (TII+0% Mac: 53.9614.1 pg/ml; TII+5% Mac:
48.9611.5 pg/ml; TII+10% Mac: 95.9646.4 pg/ml; TII+15%
Mac: 72.7615.0 pg/ml; TII+20% Mac: 67.3613.5 pg/ml) (n = 3,
Figure 5B). However, IL-6 levels from stimulated co-cultures of
TII cells and 20% macrophages was significantly reduced over
levels for stimulated macrophages alone (#p,0.05).
Alveolar macrophages significantly increase TI cell
cytokine production in the presence of LPS
The addition of macrophages to TII cells resulted in an increase
in cytokine production after treatment with LPS, albeit to levels
less than that for macrophages alone. Given that TI cells also share
a microenvironment with macrophages, we performed similar
Figure 4. FACS TII cells. A. Cytokine expression in non-FACS TII cells is greater than in FACS TII cells. TNF-a and IL-6 levels were higher in TII cells
isolated in the conventional manner (non-FACS) than in FACS-isolated TII cells after treatment with LPS (10 mg/ml). TNF-a levels in FACS TII cells were
97% lower than in non-FACS TII cells (n = 7, *p,0.05). Similarly, IL-6 levels in FACS TII cells were 77% lower than in non-FACS TII cells (n = 6, *p,0.05).
Results are expressed as mean level of cytokine6 SEM. B. Immunohistochemistry of FACS TII cells. A cytocentrifuged preparation of FACS TII cells was
double-stained with a marker for TII cells, RTII70 (green), and a marker for TI cells, RTI40 (red). The white arrow points to the lone TI cell in the field.
The corresponding phase contrast image is shown. Magnification is 206.
doi:10.1371/journal.pone.0055545.g004
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experiments with TI cells. The addition of escalating numbers of
macrophages to cultured TI cells prior to stimulation of the co-
culture with LPS resulted in a dramatic dose-dependent increase
in TNF-a (TI+0% Mac: 997.26183.9 pg/ml; TI+5% Mac:
4198.56680.5 pg/ml; TI+10% Mac: 8653.461957.6 pg/ml;
TI+15% Mac: 11303.462749.0 pg/ml; TI+20% Mac:
15492.462238.8 pg/ml) and IL-6 (TI+0% Mac:
1201.9640.6 pg/ml; TI+5% Mac: 1911.16131.3 pg/ml;
TI+10% Mac: 2345.96138.2 pg/ml; TI+15% Mac:
3265.2678.1 pg/ml; TI+20% Mac: 4013.46953.2 pg/ml) ex-
pression that was significantly greater than the addition of the
same number of macrophages to cultured FACS-isolated TII cells.
These results not only reinforce our findings that TI cells produce
more cytokines per cell than TII cells both at baseline and upon
LPS exposure, but also reveal that macrophages have a more
profound effect on TNF-a and IL-6 secretion on TI cells than TII
cells in response to LPS (Figure 5A & B). Furthermore, LPS
stimulation of a co-culture of macrophages and TI cells produced
significantly more TNF-a and IL-6 than LPS stimulation of
macrophages alone, suggesting that interplay between macro-
phages and TI cells clearly enhances immune system activation.
Conditioned media from LPS-stimulated macrophages
increases baseline TI cell cytokine expression
Soluble factors present in conditioned media could be one
explanation for the sizeable cytokine response of TI cells co-
cultured with macrophages prior to LPS stimulation. In an
attempt to gain insight into how macrophages may promote such a
heightened cytokine response in TI cells, we collected the
supernatant from cultured macrophages (10% Mac) that had
been stimulated with LPS and then added the conditioned media
to cultured TI cells. Conditioned media from LPS-stimulated
macrophages (10% Mac) increased TI cell TNF-a production
(4111.26195.6 pg/ml), but not nearly to the levels seen after LPS
addition to co-cultures of TI cells and macrophages. This same
macrophage conditioned media, however, blunted the degree of
TI cell IL-6 production (337.0631.2 pg/ml) when compared to
LPS-treated TI cell IL-6 expression, which is in contrast to the
high levels of IL-6 measured in LPS-stimulated co-cultures of TI
cells and macrophages. Conditioned media from LPS-stimulated
macrophages did not significantly increase TII cell cytokine
production over TII cells stimulated with LPS, nor did
conditioned media from LPS-stimulated TII cells alter macro-
phage cytokine production over LPS treatment alone (results not
shown). The addition of conditioned media from LPS-stimulated
TI cells to cultured macrophages did increase TNF-a
(4956.76654.1 pg/ml) and IL-6 (446.3613.8 pg/ml) levels above
those seen with the addition of LPS to macrophages (10% Macs)
alone (Figure 6), but again, less than the levels seen with the co-
culture of TI cells and macrophages after LPS treatment (Figure 5).
These results suggest that while substances secreted by activated
macrophages can stimulate TI cell production of TNF-a and
inhibit TI cell production of IL-6, cell-cell interaction between
macrophages and TI cells significantly enhances the cytokine
production of both TNF-a and IL-6, additionally overcoming the
inhibition of TI cell IL-6 production by activated macrophage
conditioned media.
Exogenous surfactant decreases LPS-stimulated TI cell
cytokine production
It has been long reported that surfactant can decrease the
degree of lung inflammation in response to endotoxin stimulation
[33–35]. These studies, coupled with our results revealing a
decrease in IL-6 production in co-cultures of TII cells and
macrophages treated with LPS, prompted us to investigate the role
of surfactant in cytokine expression in both TI and TII cells. The
addition of exogenous rat surfactant (5 or 10 mg/ml) to cultured TI
cells did not alter cytokine production at baseline, but significantly
blunted the cytokine response of TI cells to LPS for IL-6 (LPS:
1201.9640.6 pg/ml; LPS +5 mg/ml surfactant: 823.66102.4 pg/
ml; LPS +10 mg/ml surfactant: 782.8671.1 pg/ml; *p,0.05).
Levels for TNF-a in TI cells treated with surfactant and LPS (LPS
+5 mg/ml surfactant: 886.8699.1 pg/ml; LPS +10 mg/ml surfac-
tant: 892.76142.6 pg/ml) were not significantly different than TI
cells stimulated with LPS alone (1256.36259.2 pg/ml)(Figure 7).
The addition of exogenous rat surfactant (5 or 10 mg/ml) to TII
cells did not alter cytokine production in response to LPS (data not
shown).
LPS-induced cytokine response in TI cells may be due to
stimulation of the NF-kB/IkB pathway
The NF-kB/IkB pathway has been implicated in the inflam-
matory cascade caused by a variety of stimuli, including LPS, in
TII cells [29,36–38]. LPS, acting through the toll-like receptor 4
(TLR4), can activate the phosphorylation of IKKa/b, which
allows phosphorylation of IkB within the NF-kB complex, leading
to ubiquitination of the IkB complex and release of NF-kB,
allowing its translocation to the nucleus where it enhances
transcription of various inflammatory mediators. Whether this
mechanism of inflammation was present in TI cells was unclear.
Using immunohistochemistry, phospho-IKKa/b staining was
present in cultured TI cells as early as 10 minutes after LPS
stimulation, with a progressive reduction in staining intensity at
30 minutes, 1 hour, 4 hours, 8 hours and 18 hours (Figure 8A).
Similar staining was seen in TII cells (data not shown). NF-kB
expression, as measured by qPCR in cultured cells, is elevated in
both TI and TII cells after LPS stimulation, suggesting that LPS
may act via the well-described NF-kB/IkB pathway in both cell
types to stimulate cytokine secretion (Figure 8B).
Discussion
The alveolar epithelium has a number of very important
functions, primary among them gas exchange and existence as a
tight barrier to separate organism from environment. Alveolar TII
cells have traditionally been considered the immune cell of the
alveolar epithelium as this cell produces surfactant, cytokines and
chemokines, all of which have been implicated as being important
factors in lung immunity. TII cells, however, only cover
approximately 5% of the internal surface area of the lung, while
TI cells cover the remaining 95% [8], prompting the question of
whether TI cells could participate in the innate immune response
since they comprise the majority of the epithelial barrier. Earlier,
Mason and colleagues had studied TII cells that had been cultured
until they exhibited phenotypic characteristics similar to TI cells
(TI-like cells) and demonstrated that after LPS or viral stimulation,
these cells could produce CINC-2, CINC-3, LIX, MIP-2 and
MCP-1 [39,40], suggesting the possibility that TI cells could play a
role in innate immunity. Prior methods of TI cell isolation [41]
involved labeling the cells with magnetic beads and performing
both positive and negative sorting of the cells over magnetic
columns, which resulted in TI cell purities of 75–90% [42,43]. But
as techniques became available to isolate relatively pure popula-
tions of TI cells via FACS, we employed such methods to study
primary alveolar TI cells. We were able to recently report that TI
cells are capable of producing TNF-a, IL-6 and IL-1b when
exposed to LPS [9], advocating a role for TI cells in the innate
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immune response in the lung. Our current study reports not only
that TI cells are able to produce a wide range of cytokines,
chemokines, and other mediators of inflammation, but that there is
differential expression of a number of these mediators between TI
and TII cells, suggesting different roles for these cell types in the
inflammatory response of the lung.
To gain a broader view of the potential for TI cells to
participate in lung inflammation, we performed PCR array
analysis comparing control and LPS-stimulated TI and TII cells.
There was a large number of inflammatory mediators more highly
expressed in TI cells compared to TII cells at baseline, with 43 of
the 84 genes demonstrating fold-increases .2 that were statisti-
cally significant. Similar widespread gene induction was seen in
LPS-injured TI cells, with TI cells having much higher-fold gene
expression than TII cells from the same injured animals. With
.50% of the genes assayed exhibiting higher expression in TI cells
from either control or LPS-injured animals when compared to TII
cells, we expected a larger number of genes to be up-regulated
upon comparison between either control TI and LPS-treated TI
cells or control TII and LPS-treated TII cells. When comparing
control and LPS-treated TI cells, only three genes were
significantly induced in LPS-treated TI cells versus controls.
Similarly, in our comparison of control and LPS-treated TII cells,
only five genes were more highly expressed in LPS-treated TII
Figure 5. Cytokine production in LPS-stimulated macrophages and alveolar epithelial cells. TNF-a (Figure 5A) or IL-6 (Figure 5B) cytokine
expression in TI cells co-cultured with progressively higher concentrations of macrophages significantly increased TNF-a and IL-6 cytokine production
in a dose-dependent manner after stimulation with LPS (10 mg/ml) (n = 4 for each set of experiments). Addition of macrophages to TII cells did not
significantly alter TNF-a or IL-6 production from results obtained examining LPS-treated macrophages alone, except in TII cells co-cultured with 20%
macrophages, where IL-6 levels were significantly lower. Results are expressed as mean level of cytokine in pg/ml 6 SEM, *p,0.05.
doi:10.1371/journal.pone.0055545.g005
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cells than controls. The relatively high expression levels of the
majority of the genes at baseline in both sets of control cells may
have rendered the up-regulation of genes after LPS treatment less
striking by comparison, leaving us to underestimate the true
number of mediators that may have been enhanced by injury.
Cell isolation, in and of itself, can trigger the immune response
by promoting cellular stress during the processes of enzymatic
digestion, tissue mincing, and filtering. Studies have shown that
TNF-a production from freshly isolated rat alveolar epithelial cells
can decrease dramatically, from 1200 pg/ml immediately after
isolation to 50 pg/ml 48 hours later [12]. Subjecting the cells
further to FACS may have contributed to the degree of stress
experienced by the cells. Additionally, alveolar epithelial cells
isolated from LPS-treated rats have not only been exposed to the
intratracheally instilled LPS, but also to growth factors, surfactant,
immune cells, endothelial cells, cytokines, chemokines and a host
of other proteins released by surrounding cells in response to LPS
that end up in the alveolar microenvironment. These products of
inflammation undoubtedly affect cytokine expression in both TI
and TII cells. Taken together, these findings suggest that the cell
isolation procedure and cell sorting may have resulted in the
production of higher levels of inflammatory mediators at baseline
in control cells that may not have been present if the cells could be
studied in vivo. Such results led us to use cultured primary cells that
had been given at least 24 hours to recover from the isolation
process before stimulation with LPS or other agents. Furthermore,
this method allowed the assay of cytokine secretion via ELISA
analysis of the conditioned media. Despite the fact that working
with cells from LPS-injured animals is the more valid in vivo model,
we used in vitro studies of cultured cells to isolate the specific
responses of each cell type to various agents and conditions.
We were very surprised to find that primary cultured FACS TII
cells produced significantly lower levels of selected cytokines than
previously published reports for LPS-stimulated TII cells [11,28],
Figure 6. Effect of conditioned media on TI cell and macrophage cytokine production. Conditioned media from LPS-stimulated
macrophages (Mac CM, n = 4, LPS 10 mg/ml) significantly increased TI cell TNF-a production but decreased IL-6 production when compared to TI cells
stimulated with LPS alone (n = 6, *p,0.05). Addition of conditioned media from LPS-stimulated TI cells (TI CM, n = 4, LPS 10 mg/ml) to macrophages
increased both TNF-a and IL-6 expression compared to macrophages stimulated with LPS alone (*p,0.05 for TNF-a). Results are expressed as mean
level of cytokine in pg/ml 6 SEM.
doi:10.1371/journal.pone.0055545.g006
Figure 7. Effect of surfactant on LPS-stimulated cytokine response in TI cells. Surfactant significantly decreased LPS-induced IL-6
production in TI cells by 43% with 5 mg/ml surfactant (n = 4) and 35% with 10 mg/ml surfactant (n = 3) when compared to IL-6 production in TI cells
stimulated with LPS alone (LPS 10 mg/ml, n = 4, *p,0.05). Surfactant also decreased the level of TNF-a production in TI cells stimulated with LPS by
,11% at both concentrations, but the reduction was not significant. Surfactant alone did not alter TNF-a or IL-6 expression in the absence of LPS
(n = 3).
doi:10.1371/journal.pone.0055545.g007
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which is ,10–30% of the cytokines liberated by primary cultured
FACS TI cells exposed to identical amounts of LPS for the same
periods of time. This finding is noteworthy, since the TII cell has
long been considered to be the immune effector cell of the alveolar
epithelium [1,44]. It can be argued that the mere act of cell
isolation, not to mention the process of FACS, may have rendered
TII cells less capable of cytokine production. However, FACS-
isolated TI cells were able to produce significantly more cytokines
than TII cells both at baseline and upon LPS treatment.
One may contend that our method of comparison of cytokine
levels in cultured TI and TII cells, plating by cell number, may not
be the ideal manner in which to contrast the inflammatory
responses of the two cell types, and that the greater surface area of
TI cells may explain why they produce more cytokines. The
surface area ratio of TI:TII cells is 43:1 [8] and the ratio of
numbers of TI:TII cells in the lung is 1:2 [45], so in this instance,
even if TII cells were to produce 43 times the amount of cytokines
after LPS treatment, their levels of TNF-a and IL-6 production
would still be less than that of TI cells. Alternative methods of
culturing cells based on protein or DNA content or surface area
ratios were considered, but have inherent problems as well,
especially since the biologically significant ratio of TI to TII cells
when comparing cell function is not known. The desire for
consistency and reproducibility within our experiments, particu-
larly when dealing with such a small number of TI cells obtained
per isolation (,16106 cells/rat) and the need to standardize our
co-culture experiments led to our use of cell number in plating our
cultures.
Since the method of TII cell isolation was the most obvious
difference between our experiments and those published by other
investigators, we hypothesized that the bulk of the measured
cytokines seen with LPS treatment of TII cells comes from the
contaminating cells within the TII cell preparation. This concern
of cell contamination contributing to the overall cytokine response
of TII cells has been expressed by other investigators [12]. Co-
culture of FACS-isolated TII cells, which have cell purities of 98–
99%, with increasing concentrations of alveolar macrophages
produced levels of TNF-a that increased in a dose-dependent
fashion and were similar to those obtained with stimulated
macrophages alone, suggesting that the contaminating macro-
phages within the non-FACS TII cell preparations account for the
majority of the TNF-a expressed when the cells are treated with
LPS. IL-6 production, however, was not significantly different in
co-cultures of FACS TII cells with macrophages stimulated with
LPS, nor did the levels of IL-6 at any FACS TII/macrophage co-
culture concentration reach those obtained from studies of LPS-
treated non-FACS TII cells (Figure 4A). These findings suggest
that there may be cells other than macrophages within the
contamination cohort of the non-FACS TII cells that contribute to
the LPS-stimulated rise in IL-6 production.
One of the most striking findings in this study was the dramatic
increase in TNF-a and IL-6 production in the co-cultures of TI
cells and macrophages. Exposing cultured TI cells to conditioned
media from LPS-treated macrophages suggested that while TI
cells do respond to inflammatory mediators liberated by activated
macrophages by increasing TNF-a secretion, cell-cell interaction
between macrophages and TI cells is a much more potent factor in
modulating TI cell cytokine release. Conditioned media from
activated macrophages decreased the levels of TI cell IL-6
compared to LPS-stimulated TI cells alone, while LPS treatment
of co-cultures of TI cells and macrophages significantly increased
IL-6 production. The IL-6 conditioned media experiments
reinforce the notion that cell-cell interaction between TI cells
and macrophages is powerful, as co-culture of these cells
overcomes the inhibition of IL-6 production in TI cells by
inhibitory mediators released by activated macrophages. While the
exact cell of origin of the IL-6 in this instance is unclear, these
results not only make a strong case for TI cells as key participants
in the immune response of the lung, but they also suggest that the
interaction between macrophages and TI cells may be equally
important.
Studies of pulmonary surfactant in the immune response have
suggested that surfactant dampens inflammation, particularly in
the face of endotoxin-stimulated lung injury [34,46,47], but the
mechanism by which this occurs has remained unclear. Surfactant
has been shown to decrease cytokine production in whole lungs
Figure 8. LPS may activate cytokines in TI cells via the NF-kB/
IkB pathway. A. LPS stimulates IKKa/b expression in TI cells.
Cytocentrifuged mixed cell preparations from LPS-treated (10 mg/ml)
TI cells were double-stained with an antibody to phospho-IKKa/b and
RTI40, a TI cell marker. A, D, G) Mixed lung cell preparation stained with
phospho-IKKa/b at various timepoints after LPS stimulation, demon-
strating decreasing staining intensity of phospho-IKKa/b over time; B, E,
H) cells stained with RTI40 to display TI cells; C, F, I) merged images
demonstrating colocalization of phospho-IKKa/b and a TI cell-specific
marker. J) Control image showing lack of staining in the absence of a
specific primary antibody; K) phase contrast image of the control slide.
Image magnification is 406. B. LPS induces NF-kB transcript in cultured
TI cells. Expression of NF-kB transcript in cultured TI cells increased after
LPS stimulation (LPS 10 mg/ml). Relative to the amount of transcript
found in TI cells at baseline (n = 4), LPS injury increased NF-kB levels by
9-fold in TI cells (n = 4, *p,0.05). LPS also increased NF-kB transcripts 8-
fold in TII cells (n = 5) over TII controls (n = 5, ** p,0.05). Data is
expressed as fold expression of NF-kB mRNA over control6 SEM and all
values were normalized to 18S.
doi:10.1371/journal.pone.0055545.g008
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[48,49], and this general finding has been attributed to the effects
of surfactant on alveolar macrophages and dendritic cells. There
have been reports that surfactant may bind members of the TLR-4
pathway or may inhibit the translocation of TLR-4 to lipid raft
domains, thus blunting TLR-4-driven cytokine production
[33,50]. Our co-cultures of TII cells and macrophages displayed
reduced levels of IL-6 when compared to IL-6 production in LPS-
treated macrophages alone, initially suggesting that surfactant may
be blunting the IL-6 response. Our findings demonstrated that
exogenous surfactant decreased TNF-a and IL-6 production in
LPS-treated TI cells, but did not significantly affect cultured TII
cells or macrophages. Given that TII cells produce surfactant,
additional surfactant may not have conferred any additional
biological effects. And while the doses utilized here have been used
in other studies, our doses in macrophages may have not been
high enough to elicit an inhibitory response [33,35,50]. Never-
theless, our studies suggest that there may be a component of
cellular interplay between TII cells and macrophages in co-culture
that is leading to a reduction in IL-6 production after LPS
stimulation. Furthermore, the fact that surfactant decreased
cytokine production in LPS-treated TI cells suggests that any
portion of the dampened inflammatory cytokine response in the
distal lung achieved through the addition of exogenous surfactant
may have been due to the actions of surfactant on TI cells alone.
Future work in determining how surfactant can affect the
immunity of TI cells may lead to a better understanding of how
surfactant modulates the immune response of the lung.
The NF-kB pathway is important in stimulating pro-inflamma-
tory cytokines and activating genes that regulate the inflammatory
response in multiple different organs, tissue and cells [51]. Up-
regulation of NF-kB has been shown to enhance cytokine
expression in TII cells but whether a similar mechanism occurs
in TI cells was not known [29,36–38]. TI cells exposed to LPS for
10 minutes demonstrated phosphorylated IKKa/b staining that
progressively decreased in intensity after 30 minutes, which
correlates with the known rapid activation of the NF-kB pathway
upon LPS stimulation [38]. In addition, NF-kB transcription was
elevated in cultured TI and TII cells stimulated with LPS after
8 hours, further suggesting that this may be one method by which
LPS induces cytokine expression in alveolar epithelial cells.
Recently, Yamamoto et al. [52] developed a conditional
transgenic mouse model of mutated RelA, an NF-kB protein,
throughout the alveolar epithelium and reported that only a small
subset of inflammatory mediators was produced by the alveolar
epithelium after LPS or Streptococci pneumoniae exposure upon
comparison of wild type to RelAD/D mice. While these are very
interesting results, comparisons between their study and ours must
be made with caution. As is often the case with transgenic mouse
models, the relative presence, or absence, of certain targeted genes
can vary, even between genotypically similar littermates [53].
Furthermore, species specific differences in the inflammatory
response have been well-reported [54–58], which may be a
primary reason for the discordant results. The authors subjected
whole lung samples from their wild type and RelAD/D mice to
PCR array analysis, whereas we focused on isolated rat TI and TII
cells. They did study isolated mouse TI cells, but only measured
production of CCL20 and CXCL5 mRNA, whereas we measured
both transcript and protein expression patterns of various pro-
inflammatory cytokines. Nevertheless, despite the differences in
study design and methods, the final message culled from both of
our reports is largely the same: alveolar TI cells may play an active
role in the innate immune response. While the differences in cell-
specific cytokine production that we observed are intriguing, there
was never the expectation that the alveolar epithelium would
produce levels of cytokines that would rival that of immune cells
such as alveolar macrophages or dendritic cells. The more relevant
question to us was whether or not TI cells could produce
cytokines, and thus participate in the innate immune response of
the lung.
Our data has shown that TI and TII cells not only respond
differently to LPS stimulation, but there exists the possibility that
the two alveolar cell types work in concert within their
microenvironment to provide a balanced inflammatory response
to infection. One could postulate that TI cells may serve to
heighten the pro-inflammatory response with enhanced cytokine
production, particularly in the presence of alveolar macrophages,
while TII cells, through the production of surfactant and relatively
modest cytokine expression, provide more of an anti-inflammatory
response by trying to contain inflammation. Future investigation
into possible mechanisms contributing to the differential inflam-
matory response of TI and TII cells to LPS, along with more
characterization of the alveolar microenvironment during injury,
are essential to better understanding the role of the alveolar
epithelium and its component cells in the innate immune response
of the distal lung. Studies to determine if the responses reported
here are stimulus-specific or if the alveolar epithelial cells respond
similarly to other respiratory insults such as viruses, gram-positive
bacteria or tobacco smoke are also warranted. Given that diseases
such as pneumonia and acute respiratory distress syndrome all
heavily impact diverse patient populations, elucidating the role of
TI and TII cells in the innate immune response could help develop
new therapies and treatment options to improve outcomes for all
affected patients.
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